Gastroresistant pharmaceutical dosage form comprising N- (2-(2-phthalimidoethoxy)-acetyl)-L-alan yl-D-glutamic acid (LK-423)

Details for Australian Patent Application No. 2005226927 (hide)

International Classifications

Event Publications

12 October 2006 PCT application entered the National Phase

PCT publication WO2005/092295 Priority application(s): WO2005/092295

23 September 2010 Application Accepted

Published as AU-B-2005226927

20 January 2011 Standard Patent Sealed

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.